Patrick Donnelly

Board Member

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

July 9, 2019
Meet the Expert: Terry Hietpas
Meet PV expert Terry Hietpas, supporting clients out of our Saint Paul, Minnesota office Read More
June 27, 2019
Gene and Cellular Therapies: Five Keys to Regulatory Success
We are living through a medical revolution. Advances in gene therapy, cell‑based… Read More
June 25, 2019
Deviations: Beyond the Basics
Move beyond the basics of deviations with recommendations from the experts. Read More
More Articles

UPCOMING Events

July 25, 2019
ISPE San Francisco 25th Annual Fun Day
Our team looks forward to this event each year, and we can’t wait to celebrate the 25th anniversary with... Read More
August 15, 2019
ISPE Midwest Chapter 2019 Golf Tournament
Join us for this annual golf tournament and networking opportunity! Connect with a ProPharma Group team member... Read More
September 04, 2019
Cannabis Science Conference West
Join us at the Cannabis Science Conference, the world’s largest and most technical cannabis science expo... Read More
All Events
Contact Us